Engineered Bacteria With Programmable Gene Circuits Target Tumors With Precision
The idea of using living organisms as precision cancer-fighting agents is no longer science fiction — it is becoming an increasingly sophisticated engineering…
Found 1711 results for "cancer"
The idea of using living organisms as precision cancer-fighting agents is no longer science fiction — it is becoming an increasingly sophisticated engineering…
Spending more does not always mean screening better — and for older women on Medicare, a decade of data reveals a troubling drift toward costlier imaging…
HPV vaccination rates remain stubbornly low in parts of the United States, and the COVID-19 pandemic accelerated hesitancy in ways that oncologists and public…
Metastatic castration-resistant prostate cancer carries one of oncology's bleakest prognoses, and the antibody-drug conjugate revolution that reshaped breast…
For patients facing cancers that have exhausted standard treatment options — pancreatic adenocarcinoma, glioblastoma, castration-resistant prostate cancer…
A decade after the first FDA approval of CDK4/6 inhibitors, oncology stands at a meaningful inflection point — one where the foundational lessons from breast…
A comprehensive NIH-authored compendium identifies circulating senescence-associated secretory phenotype (SASP) factors — particularly GDF15 and Activin A…
Early-onset cancer — diagnosed before age 50 — has been climbing globally for decades, and the explanation has remained frustratingly incomplete. Genetic…
For decades, KRAS was considered undruggable — a death sentence for patients whose tumors carried mutations in this master oncogene, which drives roughly a…
Understanding how nascent tumors escape the physical constraints of healthy tissue is one of cancer biology's most consequential unsolved problems — and new…
How cancer cells manage their molecular communications under duress has long been a blind spot in tumor biology — and closing that gap could reshape…
Drug resistance remains the central unsolved problem in multiple myeloma, a blood cancer where most patients eventually relapse despite initial responses to…
Early cancer detection has long been constrained by a paradox: the cancers most likely to be cured are often the hardest to catch before symptoms appear. A…
Early cancer detection sounds like an unambiguous win, but the gap between a compelling premise and proven clinical benefit is precisely where medicine has…
A near-comprehensive national dataset revealing that substance use disorders carry a dramatically elevated mortality burden should prompt any health-conscious…
Ovarian cancer remains one of the most lethal gynecologic malignancies partly because it is rarely detected early — which is why any intervention that…
For the millions of women navigating breast cancer prevention, dietary choices remain one of the few modifiable levers available. A large prospective cohort…
For immunocompromised patients — transplant recipients, cancer patients on chemotherapy, ICU patients on broad-spectrum antibiotics — invasive Candida…
One of the most stubborn problems in oncology is cancer cells that learn to survive the very drugs designed to kill them. Multiple myeloma, a blood cancer…
Appendiceal adenocarcinoma is one of oncology's orphan diseases — so rare that standard chemotherapy regimens borrowed from colorectal cancer are used largely…